Gene Expression Profiling in Preterm Infants: New Aspects of Bronchopulmonary Dysplasia Development

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Pietrzyk, Jacek J ^a   Kwinta, Przemko ^a   Wollen, Embjorg J ^b   Bik Multanowski, Mirosław ^a   Madetko Talowska, Anna ^a   Günther, Clara Cecilie ^c   Jagła, Mateusz ^a   Tomasik, Tomasz ^a   Saugstad, Ola D ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN COMPUTING CENTER   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GESTATIONAL AGE; HUMAN; IMMATURITY; INFANT; INFLAMMATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION; UPREGULATION; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

BRONCHOPULMONARY DYSPLASIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME, HUMAN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84886026355     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078585     Document Type: Article

References (48)

1. Bhandari A, Bhandari V, (2009) Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 123: 1562-1573. doi:10.1542/peds.2008-1962. PubMed: 19482769.
2. Warburton D, Bellusci S, De Langhe S, Del Moral PM, Fleury V, et al. (2005) Molecular mechanisms of early lung specification and branching morphogenesis. Pediatr Res 57: 26R-37R. doi:10.1203/01.PDR.0000159570.01327.ED. PubMed: 15817505.
3. Thébaud B, (2007) Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology 91: 291-297. doi:10.1159/000101344. PubMed: 17575472.
4. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C, (2005) Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57: 38R-46R. doi:10.1203/01.PDR.0000159630.35883.BE. PubMed: 15817499.
5. Asikainen TM, Ahmad A, Schneider BK, White CW, (2005) Effect of preterm birth on hypoxia-inducible factors and vascular endothelial growth factor in primate lungs. Pediatr Pulmonol 40: 538-546. doi:10.1002/ppul.20321. PubMed: 16231377.
6. Janér J, Lassus P, Haglund C, Paavonen K, Alitalo K, et al. (2006) Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants. Am J Respir Crit Care Med 174: 326-330. doi:10.1164/rccm.200508-1291OC. PubMed: 16690974.
7. Lassus P, Turanlahti M, Heikkilä P, Andersson LC, Nupponen I, et al. (2001) Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987. doi:10.1164/ajrccm.164.10.2012036. PubMed: 11734455.
8. Thébaud B, Abman SH, (2007) Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175: 978-985. doi:10.1164/rccm.200611-1660PP. PubMed: 17272782.
9. Bry K, Lappalainen U, (2006) Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1b in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice. Semin Perinatol 30: 121-128. doi:10.1053/j.semperi.2006.04.009. PubMed: 16813970.
10. Nedrelow JH, Bhandari V, (2004) Interleukin (IL)-6 to vascular endothelial growth factor (VEGF) ratio predicts the development of brochopulmonary dysplasia (BPD)/death in premature infants. Pediatr Res 55: 496A-496A.
11. Vento G, Capoluongo E, Matassa PG, Concolino P, Vendettuoli V, et al. (2006) Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia. Intensive Care Med 32: 723-730. doi:10.1007/s00134-006-0138-1. PubMed: 16550369.
12. Schelonka RL, Waites KB, (2007) Ureaplasma infection and neonatal lung disease. Semin Perinatol 31: 2-9. doi:10.1053/j.semperi.2007.01.001. PubMed: 17317421.
13. Colaizy TT, Morris CD, Lapidus J, Sklar RS, Pillers DA, (2007) Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors. Pediatr Res 61: 578-583. doi:10.1203/pdr.0b013e318045be03. PubMed: 17413863.
14. Stevens T, Harrington E, Blennow M, Soll R, (2007) Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 4CD003063.
15. Kamlin C, Davis PG, (2004) Long versus short inspiratory times in neonates receiving mechanical ventilation. Cochrane Database Syst Rev 4CD004503. PubMed: 15495117.
16. Cools F, Henderson-Smart D, Offringa M, Askie L, (2009) Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 3CD000104. PubMed: 195883171763659014583909125353831168695010796129.
17. Saugstad OD, (2010) Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med 38: 571-577. PubMed: 20807008.
18. Saugstad OD, Aune D, (2011) In search of the optimal oxygen saturation for extremely low birth weight infants: a systematic review and meta-analysis. Neonatology 100: 1-8. doi:10.1159/000322001. PubMed: 21150224.
19. Askie L, Henderson-Smart D, Ko H, (2009) Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev 1CD001077.
20. Stevens TP, Dylag A, Panthagani I, Pryhuber G, Halterman J, (2010) Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia. Pediatr Pulmonol 45: 371-379. PubMed: 20232470.
21. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, et al. (2006) Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117: 1901-1906. doi:10.1542/peds.2005-1414. PubMed: 16740829.
22. Jobe AH, Bancalari E, (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723-1729. doi:10.1164/ajrccm.163.7.2011060. PubMed: 11401896.
23. Lee M-T, (2004) Power and Sample Size Considerations. In: Analysis of Microarray Expression Data. Boston: Kluwer Academic Publishers. pp. pp. 191-236.
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:10.1186/gb-2004-5-10-r80. PubMed: 15461798.
25. Bengtsson H, Simpson K, Bullard J, Hansen K, (2008) aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Tech Rep #745Department of Statistics, University of California, Berkeley.
26. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:10.1093/biostatistics/4.2.249. PubMed: 12925520.
27. Smyth GK, (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3Article3, Article3 PubMed: 16646809.
28. Smyth GK, (2005) Limma: Linear Models for Microarray Data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, eds. Bioinformatics and Computional Biology Solutions using R and Bioconductor. New York: Springer Verlag. pp. pp. 397-420.
29. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 57: 289-300.
30. Hollander M, Wolfe DA, (1973) Kendall and Spearman Tests. In: Nonparametric Statistical Methods. New York: John Wiley & Sons. pp. pp. 185-194.
31. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. PubMed: 19131956.
32. Huang DW, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/gkp505. PubMed: 19033363.
33. Bhering CA, Mochdece CC, Moreira ME, Rocco JR, Sant'Anna GM, (2007) Bronchopulmonary dysplasia prediction model for 7-day-old infants. J Pediatr (Rio, 83: 163-70. PubMed: 17380230 J) 83: 163-170. PubMed: 17380230.
34. Henderson-Smart DJ, Hutchinson JL, Donoghue DA, Evans NJ, Simpson JM, et al. (2006) Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed 91: pp. F40-F45. PubMed: 16131530.
35. O'Reilly MA, (2001) DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair. Am J Physiol Lung Cell Mol Physiol 281: L291-L305. PubMed: 11435201.
36. Sánchez I, Dynlacht BD, (2005) New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol 16: 311-321. doi:10.1016/j.semcdb.2005.02.007. PubMed: 15840440.
37. Lepock JR, (2005) How do cells respond to their thermal environment? Int J Hyperthermia 21: 681-687. doi:10.1080/02656730500307298. PubMed: 16338849.
38. Kriebitzsch C, Verlinden L, Eelen G, Tan BK, Van Camp M, et al. (2009) The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach. Anticancer Res 29: 3471-3483. PubMed: 19667141.
39. Lapillonne A, Clarke SD, Heird WC, (2004) Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care. 7: 151-156. doi:10.1097/00075197-200403000-00008. PubMed: 15075705.
40. Huang Y, Wange RL, (2004) T Cell Receptor Signaling: Beyond Complex Complexes. J Biol Chem 279: 28827-28830. doi:10.1074/jbc.R400012200. PubMed: 15084594.
41. Cheng J, Montecalvo A, Kane LP, (2011) Regulation of NF-kappaB induction by TCR/CD28. Immunol Res 50: 113-117. doi:10.1007/s12026-011-8216-z. PubMed: 21717079.
42. James JR, McColl J, Oliveira MI, Dunne PD, Huang E, et al. (2011) The T-cell receptor triggering apparatus is composed of monovalent or monomeric proteins. J Biol Chem. doi:10.1074/jbc.M111.219212.
43. Beyer T, Busse M, Hristov K, Gurbiel S, Smida M, et al. (2011) Integrating signals from the T-cell receptor and the interleukin-2 receptor. PLOS Comput Biol 7: e1002121. PubMed: 21829342.
44. Speer CP, (2006) Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 11: 354-362. doi:10.1016/j.siny.2006.03.004. PubMed: 16702036.
45. Kaminski MM, Sauer SW, Klemke CD, Süss D, Okun JG, et al. (2010) Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression. J Immunol 184: 4827-4841. doi:10.4049/jimmunol.0901662. PubMed: 20335530.
46. Grundberg E, Small KS, Hedman AK, Nica AC, Builet A, et al. (2012) Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 44: 1084-1089. doi:10.1038/ng.2394. PubMed: 22941192.
47. Rudkowska I, Raymond C, Ponton A, Jacques H, Lavigne C, et al. (2011) Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. OMICS 5: 1-7. PubMed: 21194298.
48. Kim K, Zakharkin SO, Allison DB, (2010) Expectations, validity, and reality in gene expression profiling. J Clin Epidemiol 63: 950-959. doi:10.1016/j.jclinepi.2010.02.018. PubMed: 20579843.